Skip header and navigation

2 records – page 1 of 1.

The Norwegian versions of the Chronic Pain Acceptance Questionnaire CPAQ-20 and CPAQ-8 - validation and reliability studies.

https://arctichealth.org/en/permalink/ahliterature290282
Source
Disabil Rehabil. 2017 07; 39(14):1441-1448
Publication Type
Journal Article
Validation Studies
Research Support, Non-U.S. Gov't
Date
07-2017
Author
Hilde Eide
Lena Leren
Øystein Sørebø
Author Affiliation
a Faculty of Health Sciences , University College of Southeast-Norway , Drammen , Norway.
Source
Disabil Rehabil. 2017 07; 39(14):1441-1448
Date
07-2017
Language
English
Publication Type
Journal Article
Validation Studies
Research Support, Non-U.S. Gov't
Keywords
Adult
Chronic Pain - rehabilitation
Factor Analysis, Statistical
Female
Humans
Male
Middle Aged
Norway
Pain Measurement - methods
Randomized Controlled Trials as Topic
Regression Analysis
Reproducibility of Results
Surveys and Questionnaires - standards
Translating
Visual Analog Scale
Abstract
The aim of this study was to test the validity and reliability of the translated Norwegian version of the Chronic Pain Acceptance Questionnaire (CPAQ-20) and the shorter version CPAQ-8 based on the same data.
The sample consisted of 120 women with chronic widespread musculoskeletal pain (CWP). The respondents completed CPAQ-20 and visual analogue scales (pain, fatigue, sleep problems and depression), General Health Questionnaire-12, The Pain Catastrophizing Scale, Fibromyalgia Impact Questionnaire and SF-8. Confirmatory factor analyses were performed on a one-factor baseline model, the previous validated CPAQ-20 and CPAQ-8 models, as well as an exploratory generated model based on the current sample.
The two-factor model of CPAQ-20 and a two-factor model of CPAQ-8 obtained adequate model fit and outperformed the baseline model. The exploratory factor, analysis-generated two-factor model obtained only a marginally better fit, supporting the two-dimensional model of CPAQ-20. CPAQ-20 and CPAQ-8 had Cronbach's alphas between 0.75 (Pain Willingness subscales both versions) and 0.85. Both scales correlated significantly in the hypothesised direction with all the other scales.
The Norwegian versions of CPAQ-20 and CPAQ-8 are reliable assessment tools with good construct validity for measurement of acceptance. Future studies should validate the scales in other Norwegian samples. Implication for Rehabilitation CPAQ-20 and CPAQ-8 are valid Norwegian instruments for measuring acceptance of pain. Acceptance of pain is an important process in the rehabilitation of persons with chronic widespread pain. Treatment models supporting acceptance can now be developed and measured further in Norway.
PubMed ID
27375090 View in PubMed
Less detail

Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations.

https://arctichealth.org/en/permalink/ahliterature300144
Source
Epidemiology. 2019 03; 30(2):230-233
Publication Type
Journal Article
Research Support, Non-U.S. Gov't
Validation Studies
Date
03-2019
Author
Peter Alping
Fredrik Piehl
Annette Langer-Gould
Thomas Frisell
Author Affiliation
From the Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Source
Epidemiology. 2019 03; 30(2):230-233
Date
03-2019
Language
English
Publication Type
Journal Article
Research Support, Non-U.S. Gov't
Validation Studies
Keywords
Antirheumatic Agents - therapeutic use
Cohort Studies
Humans
Immunotherapy - statistics & numerical data
Magnetic Resonance Imaging - statistics & numerical data
Medical Records - statistics & numerical data
Multiple Sclerosis - drug therapy - epidemiology - physiopathology
Pharmacoepidemiology - standards
Recurrence
Registries - standards
Regression Analysis
Sweden - epidemiology
Abstract
The Swedish Multiple Sclerosis Register is a national register monitoring treatment and clinical course for all Swedish multiple sclerosis (MS) patients, with high coverage and close integration with the clinic. Despite its great value for epidemiologic research, it has not previously been validated. In this brief report, we summarize a large validation of >3,000 patients in the register using clinical chart review in the context of the COMBAT-MS study. While further improving the data quality for a central cohort of patients available for future epidemiologic research, this study also allowed us to estimate the accuracy and completeness of the register data.
PubMed ID
30721167 View in PubMed
Less detail